For Release: Tuesday, October 6, am EDT Contact: Edmond Byrnes, PhDNIH announces Common Fund 2015 High-Risk,

First Page		Document Content
Date: 2015-10-12 14:16:29 National Institutes of Health Science and technology in the United States Health United States Department of Health and Human Services National Institute of General Medical Sciences National Eye Institute National Institute of Diabetes and Digestive and Kidney Diseases National Human Genome Research Institute Transformative research National Institute of Allergy and Infectious Diseases Elias Zerhouni National Institute of Mental Health		For Release: Tuesday, October 6, am EDT Contact: Edmond Byrnes, PhDNIH announces Common Fund 2015 High-Risk, Add to Reading List Source URL: www.igs.umaryland.edu Download Document from Source Website File Size: 187,22 KB Share Document on Facebook

	National Institute of Allergy and Infectious Diseases Awards MERS/SARS Coronavirus Drug Research Grant to Autoimmune Technologies FOR IMMEDIATE RELEASE New Orleans, June 24, Autoimmune Technologies LLC, a New Orle DocID: 1uTGp - View Document
	Emerging and Re-emerging Infectious Diseases developed under a contract from the National Institutes of Health in collaboration with the National Institute of Allergy and Infectious Diseases DocID: 1uoM7 - View Document
	Sanaria® PfSPZ Malaria Vaccine Wins 2014 Vaccine Industry Excellence Award for “Best Prophylactic Vaccine” Rockville, MD - Sanaria received the 2014 Vaccine Industry Excellence Award for the “Best Prophylactic Vac DocID: 1rm3H - View Document
	Off i ce O f C l i nic al S it e Oversight National Institute of Allergy and Infectious Diseases (NIAID) MOB Report 4th Edition DocID: 1qxvn - View Document
	Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease. Testimony before the DocID: 1qsO1 - View Document